4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0002056093-25-000005
Chief Medical Officer sold 9,546 shares at an average $22.01 ($210,144)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Markus Richard · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-16 | Sale : show line 1 in the form 10b5-1 | −5,052 | $21.88 | $110,559 | 70,141 | D |
| 2025-12-17 | Sale : show line 2 in the form 10b5-1 | −4,494 | $22.16 | $99,585 | 65,647 | D |
| Open-market sales · 9,546 sh · avg $22.01 · $210,144 | ||||||
Loading xslF345X05/wk-form4_1766097334.xml…